AMBRISENTAN Devatis cpr pell 5 mg 30 pce

7680677990021 CH-67799 C02KX02 02.07.1.

Reimbursement limitations:

VOLIBRIS

Traitement de l’hypertension artérielle pulmonaire idiopathique (HTAPI) et de l’HTAP associée à des affections de …

AMBRISENTAN Devatis cpr pell 5 mg 30 pce
AMBRISENTAN Devatis cpr pell 5 mg 30 pce
AMBRISENTAN Devatis cpr pell 5 mg 30 pce
1 / 3
google

Details

Product number
6779901
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
Filmtablette: ambrisentanum 5 mg, lactosum monohydricum 70.725 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 187 µg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, E 171, E 129 42.3 µg, pro compresso obducto.

Articles (1)

Ambrisentan Devatis 5 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/08/2023
Patient information leaflet
Français
25/08/2023
Patient information leaflet
Italien
25/08/2023
Professional SmPC
Allemand
25/08/2023
Professional SmPC
Français
25/08/2023
Professional SmPC
Italien
25/08/2023

Detailed composition

Substance Quantity Type Category
FTAB
5.0 MG Substance Wirkstoff (Principe actif)
FTAB
70.725 MG Substance HBESI
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
187.0 UG Substance HBESI
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FNIDK
FTAB
42.3 UG Substance HBESI

Reimbursement information

Public price
CHF 1093.70
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/11/2021

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
67799
Drug name
Ambrisentan Devatis, Filmtabletten
Galenic form
FILM
ATC Code
C02KX02
Authorization status
Z
Dispensation category
B
First authorization
29/10/2020
Authorization expiration date
31/12/9999
IT number
02.07.1.
Domain
Human medicine
Field of application
Pulmonale arterielle Hypertonie

Packaging details

Description (FR)
AMBRISENTAN Devatis cpr pell 5 mg 30 pce
Description (DE)
AMBRISENTAN Devatis Filmtabl 5 mg 30 Stk
Market launch
29/10/2020
Narcotic (BTM)
No

Original drug

Volibris, Filmtabletten
CHF 1195.35
View original

Other packaging sizes

AMBRISENTAN Devatis cpr pell 5 mg 10 pce
10 TABL
View
AMBRISENTAN Devatis cpr pell 10 mg 10 pce
10 TABL
View
AMBRISENTAN Devatis cpr pell 10 mg 30 pce
30 TABL
View